These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31443991)

  • 1. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
    Xia R; Sun S; Shen M; Zhang L; Zhuang G
    Vaccine; 2019 Sep; 37(39):5868-5876. PubMed ID: 31443991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China.
    Cui T; Zhang X; Wang Q; Yue N; Bao C; Jiang R; Xu S; Yuan Z; Qian Y; Chen L; Hang H; Zhang Z; Sun H; Jin H
    Hepatol Res; 2024 Feb; 54(2):142-150. PubMed ID: 37706554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use the Markov-decision tree model to optimize vaccination strategies of hepatitis E among women aged 15 to 49].
    Chen ZM; Ji SB; Shi XL; Zhao YY; Zhang XF; Jin H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):267-271. PubMed ID: 28231679
    [No Abstract]   [Full Text] [Related]  

  • 4. Health economic evaluation of immunization strategies of hepatitis E vaccine for elderly population.
    Cheng X; Zhao Y; Zhang X; Jin H; Min J
    Hum Vaccin Immunother; 2017 Aug; 13(8):1873-1878. PubMed ID: 28448739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation.
    Ankcorn MJ; Tedder RS; Cairns J; Sandmann FG
    Value Health; 2020 Mar; 23(3):309-318. PubMed ID: 32197726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions.
    Zhao Y; Zhang X; Zhu F; Jin H; Wang B
    Hum Vaccin Immunother; 2016 Aug; 12(8):2003-2009. PubMed ID: 26900799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effective analysis of seasonal influenza vaccine in elderly Chinese population].
    Chen C; Liu GE; Wang MJ; Gao TF; Jia HP; Yang H; Feng LZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct; 53(10):993-999. PubMed ID: 31607044
    [No Abstract]   [Full Text] [Related]  

  • 8. Active Tuberculosis Screening via a Mobile Health App in Myanmar: Incremental Cost-Effectiveness Evaluation.
    Htet KKK; Phyu AN; Zayar NN; Chongsuvivatwong V
    JMIR Form Res; 2023 Nov; 7():e51998. PubMed ID: 37948119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.
    Nayagam S; Conteh L; Sicuri E; Shimakawa Y; Suso P; Tamba S; Njie R; Njai H; Lemoine M; Hallett TB; Thursz M
    Lancet Glob Health; 2016 Aug; 4(8):e568-78. PubMed ID: 27443782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
    Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD
    BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of dengue vaccination in ten endemic countries.
    Zeng W; Halasa-Rappel YA; Baurin N; Coudeville L; Shepard DS
    Vaccine; 2018 Jan; 36(3):413-420. PubMed ID: 29229427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness of community-based treatment of chronic hepatitis B in China].
    Zhang SX; Yang PC; Cai YL; Lin Y; Zou YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):860-867. PubMed ID: 28738456
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of couple-based immunization strategy to prevent mother-to-child transmission of hepatitis B virus in China: A decision-analytic Markov model.
    Jing W; Liu J; Wu Y; Ma Q; Liu M
    EClinicalMedicine; 2020 Feb; 19():100264. PubMed ID: 32055793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An economic evaluation of the current measles vaccination program: A case study in Zhejiang Province, east China.
    Zeng Y; Luo M; Chen J; He H; Deng X; Xie S; Fang Y
    Vaccine; 2019 May; 37(23):3071-3077. PubMed ID: 31040084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
    Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
    Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
    Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cytomegalovirus vaccination for females in China: A decision-analytical Markov study.
    Yin MZ; Gu YY; Shu JT; Zhang B; Su M; Zhang LP; Jiang YH; Qin G
    Vaccine; 2023 Sep; 41(40):5825-5833. PubMed ID: 37580210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.
    Wang Y; Shi JF; Wang L; Yan Y; Yao H; Dai M; Chen T; Qu C
    Int J Infect Dis; 2019 Jan; 78():130-139. PubMed ID: 30466898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission.
    Orellano PW; Reynoso JI; Stahl HC; Salomon OD
    Vaccine; 2016 Jan; 34(5):616-621. PubMed ID: 26724542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
    Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G
    Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.